Are you Dr. Waterfield?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 53 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1020 Southhill Dr
Ste 200
Cary, NC 27513Phone+1 919-659-1678
Summary
- Dr. William Waterfield, MD is an oncologist in Cary, North Carolina. He is currently licensed to practice medicine in Wisconsin, Montana, and Georgia.
Education & Training
- Penn State Milton S Hershey Medical CenterResidency, Internal Medicine, 1976 - 1977
- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1975 - 1976
- UPMC Medical Education (Harrisburg)Residency, Internal Medicine, 1973 - 1975
- University of Cincinnati Medical Center Inc.Internship, Transitional Year, 1972 - 1973
- Lewis Katz School of Medicine at Temple UniversityClass of 1972
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- MD State Medical License 1979 - 2023
- MT State Medical License 2016 - 2022
- TN State Medical License 2013 - 2022
- GA State Medical License 2013 - 2021
- WA State Medical License 2012 - 2021
- WI State Medical License 2017 - 2021
- SD State Medical License Active through 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- Study of Denileukin Diftitox in Participants With Stage IIIC and Stage IV Melanoma Start of enrollment: 2010 Jun 22
Publications & Presentations
PubMed
- 68 citationsPatient Responses to Ipilimumab, a Novel Immunopotentiator for Metastatic Melanoma: How Different are these From Conventional Treatment Responses?Gregory K. Pennock, William Waterfield, Jedd D. Wolchok
American Journal of Clinical Oncology. 2012-12-01 - 908 citationsIpilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging studyJedd D. Wolchok, Bart Neyns, Gerald P. Linette, Sylvie Negrier, Jose Lutzky
The Lancet. Oncology. 2010-02-01 - 3 citationsResults of curative therapy for esophageal cancer in a community training hospital.Andrew M. Averbach, Alisher Akbarov, Todd Sidel, Karl Mech, Bahman Parandian
International Surgery. 2002-01-01